Home > Clinical Trials

Saved trials

Unknown status
NCT01816997
The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose
160 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Diabetes
Completed
NCT01648790
A Study of Prasugrel in Healthy Participants
20 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Healthy Volunteers
Unknown status
NCT01456364
Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing
70 Enrollment(s)
3 Study location(s)
Interventional (Phase IV)
Coronary Heart Disease
Completed
NCT01835353
High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
82 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Platelet Reactivity
Terminated
NCT00738972
Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)
12 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Hypertension
Completed
NCT01764295
Clinical Study for Patients With Hypertension Associated With Dyslipidemia
150 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Hypertension
Dyslipidemia
Terminated
NCT00467831
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
3 Enrollment(s)
1 Study location(s)
Interventional (Phase I|Phase II)
Hermansky-Pudlak Syndrome (HPS)
Pulmonary Fibrosis
Oculocutaneous Albinism
Platelet Storage Pool Deficiency
Metabolic Disease
Completed
NCT01907373
Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers
12 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Drug Interaction of Olmesartan in Healthy Chinese Volunteers